An update in recurrent spontaneous abortion

被引:246
|
作者
Pandey M.K. [1 ]
Rani R. [2 ]
Agrawal S. [3 ]
机构
[1] Division of Molecular Immunology, Cincinnati Children's Hospital Medical Center, MLC 7021 TCH RF 5503, Cincinnati, OH 45229-3039
[2] Department of Biology, University of Texas, San Antonio, TX
[3] Department of Medical Genetics, SGPGIMS, Lucknow
关键词
1α; 25 -Dihydroxy-vitamin-D3 (VD3) therapy; ANA (anti-nuclear antibody); APA (anti-phospho lipid antibody); Aspirin/Heparin therapy; Immunoglobulin (IVIg) therapy; Lymphocyte immunotherapy; RSA (Recurrent spontaneous abortion);
D O I
10.1007/s00404-004-0706-y
中图分类号
学科分类号
摘要
Recurrent spontaneous abortion (RSA) is defined as three or more consecutive pregnancy losses prior to the 20th week of gestation. The etiology of recurrent spontaneous abortion is often unclear and may be multifactorial, with much controversy regarding diagnosis and treatment. Reasonably accepted etiologic causes include, genetics, anatomical, endocrine, placental anomalies, hormonal problems, infection, smoking and alcohol consumption, exposure to environmental factors, psychological trauma and stressful life event, certain coagulation and immunoregulatory protein defects. Detection of an abnormality in any of these areas may result into specific therapeutic measures, with varying degrees of success. However, the majority of cases of RSA remains unexplained and is found to be associated with certain autoimmune (APA, ANA, ACA, ATA, AECA) and alloimmune (APCA, Ab2, MLR-Bf) antibodies that may play major role in the immunologic failure of pregnancy and may lead to abortion. Alteration in the expression of HLA-G molecules, T-helper-1 (Th-1) pattern of cytokines and natural killer (NK) cells activity may also induce abortion. Various forms of treatment like antithrombotic therapies such as aspirin and heparin, intravenous immunoglobulin (IVIg) therapy, immunotherapy with paternal lymphocytes and vitamin D3 therapy are effective mode of treatment for unexplained cause of fetal loss in women with RSA. © Springer-Verlag 2005.
引用
收藏
页码:95 / 108
页数:13
相关论文
共 50 条
  • [32] Recurrent spontaneous abortion in women with bleeding disorders
    Halimeh, S.
    Rott, H.
    Kappert, G.
    Siebert, M.
    THROMBOSIS RESEARCH, 2013, 131 : S95 - S95
  • [33] RECURRENT SPONTANEOUS-ABORTION - EDITORS FORMULATION
    NOVY, MJ
    SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1988, 6 (02): : 235 - 237
  • [34] Endometrial differential biomarkers of recurrent spontaneous abortion
    Urquiza, F.
    Ferrer, C.
    Incera, E.
    Azpiroz, A.
    Junovich, G.
    Pappalardo, C.
    Guerrero, G.
    Pasqualini, S.
    Gutierrez, G.
    HUMAN REPRODUCTION, 2013, 28 : 220 - 220
  • [35] Genetic Regulation of Recurrent Spontaneous Abortion in Humans
    Vaiman, Daniel
    BIOMEDICAL JOURNAL, 2015, 38 (01) : 11 - 24
  • [36] Definition and Multiple Factors of Recurrent Spontaneous Abortion
    La, Xiaolin
    Wang, Wenjuan
    Zhang, Meng
    Liang, Li
    ENVIRONMENT AND FEMALE REPRODUCTIVE HEALTH, 2021, 1300 : 231 - 257
  • [37] IMMUNOLOGICAL MECHANISMS IN RECURRENT SPONTANEOUS-ABORTION
    HILL, JA
    ANDERSON, DJ
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 1990, 38 (1-2) : 111 - 119
  • [38] Preconception care of patients with recurrent spontaneous abortion
    Qiao, Jie
    REPRODUCTIVE AND DEVELOPMENTAL MEDICINE, 2019, 3 (02) : 63 - 68
  • [39] IS IMMUNOTHERAPY JUSTIFIED FOR RECURRENT SPONTANEOUS-ABORTION
    MARZUSCH, K
    TINNEBERG, H
    MUELLERECKHARDT, G
    KAVERI, SV
    HINNEY, B
    REDMAN, C
    LANCET, 1992, 339 (8808): : 1543 - 1543
  • [40] HISTOCOMPATIBILITY STUDIES IN RECURRENT SPONTANEOUS-ABORTION
    KILPATRICK, DC
    HUMAN REPRODUCTION, 1994, 9 (06) : 1197 - 1198